Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2024-05-16 00:00:00 ET · period of report 2024-05-10 · accession 0001415889-24-013355 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-16 | 2024-05-10 | MIRM | Peetz Christopher | CEO, Dir | A - Grant | $21.05 | +817 | 92.8K | +0.9% | +$17.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-10 | A | A | 817 | $21.05 | 92,770 | D | — | — |